ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Rolagem de Taxa Média de Depósitos Interfinanceiros de Um Dia - Janeiro 2033 - Janeiro 2037

Rolagem de Taxa Média de Depósitos Interfinanceiros de Um Dia - Janeiro 2033 - Janeiro 2037 (DIFF33F37)

0.00
0.00
(0.00%)
Closed July 30 5:25PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.00
Price Change
0.00
Change %
0.00%
Name
Rolagem de Taxa Média de Depósitos Interfinanceiros de Um Dia - Janeiro 2033 - Janeiro 2037
Symbol
DIFF33F37
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Bid
0.00
Ask
0.00
Open
-
High
0.00
Low
0.00
Close
-
Previous Close
0.00
Market
BM&F - Brazilian Commodities
Type
Future Spread

DIFF33F37 Latest News

Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.

NUTLEY, N.J. and BASEL, Switzerland, Jan. 2 /PRNewswire-FirstCall/ -- Roche (SWX: ROG.VX; RO.S; OTCQX; RHHBY) today announced that its wholly-owned subsidiary 900 North Point Acquisition...

Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia

MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that it has dosed the first patient in its Phase 2 clinical study of the effect of...

BridgewaterEquity.com Free Fundamental Sector & Market Research on COLM, EGLE, FMCN and MEMY

LONDON -- (Marketwire) -- 12/22/08 -- BridgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers...

Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908

MONTVALE, N.J., Dec. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced positive results from its Phase 1 program for R4996/MEM 63908, a partial agonist of...

Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma

Study to Evaluate Proof-of-Concept for Company's Lead PDE4 Inhibitor MONTVALE, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that it has...

Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement

MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that the NASDAQ Listing and Hearing Review Council has determined that the Company...

Memory Pharmaceuticals Receives NASDAQ Decisions

- Company Granted Stay of Delisting by NASDAQ Review Council - MONTVALE, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that, on December 3...

Beacon Equity Issues Technical Trade Alerts on Market Movers: DIOD, MEMY, CSUN, CLWR, BARE, CHRS

DALLAS, Nov. 26 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

NUTLEY, N.J. and MONTVALE, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Roche and Memory Pharmaceuticals (NASDAQ:MEMY) today announced that the two companies have signed a definitive merger agreement...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000FS
40000000FS
120000000FS
260000000FS
520000000FS
1560000000FS
2600000000FS
Indices
Commodities
Forex
OILCRUDE75.470.0950.13%
OILBRENT78.98-0.165-0.21%
NATGAS2.08250.0150.73%
XAUUSD2,389.6558.240.35%
XAGUSD27.8380.01150.04%
XPTUSD1,087.2550.000.00%
COPPER4.0783-0.029-0.71%

Your Recent History

Delayed Upgrade Clock